Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveRole of NADPH oxidase in formation and function of multinucleated giant cellsSex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyCardiovascular risk may be increased in women with unexplained infertilityInflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels.Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA)Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjectsDefining a molecular portrait of physical fitness.Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes.Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.Validated methods for assessment of subclinical atherosclerosis in rheumatology.Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients.Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Lower zinc bioavailability may be related to higher risk of subclinical atherosclerosis in Korean adults.Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users.Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort.Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans.Correlative association of interleukin-6 with intima media thickness: a meta-analysis.Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa.Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children.The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort.Red blood cell distribution width as a prognostic marker of mortality in patients on chronic dialysis: a single center, prospective longitudinal study.Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosisSerum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US.Intercellular communication in atherosclerosis.Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults.Vascular health in children and adolescents: effects of obesity and diabetes.Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice.Rapid emergence of multimarker strategies in laboratory medicine.Urinary biomarkers as indicator of chronic inflammation and endothelial dysfunction in obese adolescents.Urinary proteomics in cardiovascular disease: Achievements, limits and hopes.Current role of biomarkers in carotid disease: a systematic review.Role of C-reactive protein in cerebrovascular disease: a critical review.Inflammatory markers in coronary artery disease.Association of arterial stiffness with coronary flow reserve in revascularized coronary artery disease patients.Beyond Self-Report: Performance Measures of Emotional Competencies Predict Symptoms of Depression and Anxiety, Physical Symptoms, Self-Rated Health, and Immunoregulatory Molecules.The association between chronic hepatitis C infection and cardiovascular risk.Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathwayIncreased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
P2860
Q24594814-A4B23ED7-6097-40F8-9C96-C66B98488D37Q24633426-A4B1E427-CF86-44C6-B079-26902FC10BEDQ33530066-A9338EB2-8950-4923-8B80-3FA203331D14Q33575570-678D28BE-49ED-4EF6-BD1C-42C45ADD91C6Q33602347-494CA887-5801-478F-9F40-10DFB60D42DCQ33743835-1F6940E9-6ACC-4A69-B3F7-DC7245E3B2C0Q33784462-3F48A78E-BAAA-417F-A4A3-92FEE5BD96CFQ33878112-B5F9ABC9-9973-4F14-9E4F-B118DD0384ACQ33904510-F1C3BCB9-04F2-4405-97E6-10CDC3CA4390Q34147987-3B5FEA4C-E691-4B79-9A30-80ABE539A9CDQ34164481-A5BE0DFB-6FD7-4D65-BE19-E75E7AD1D2AFQ34427727-2ABBA70B-F200-4AF1-907F-97C10687DFA8Q34875287-B4A441DA-9073-4828-8D7B-1F781C25CC41Q35040396-6E9AE4DB-A1D6-42A2-8533-CDC5FBAF8A42Q35056311-974F9575-DDEB-46CA-9D22-10AD20DF06A2Q35152108-2D5C4C2B-08E0-44C6-A7A0-4660DB20B22CQ35240627-7BAB92F4-E91E-45DD-BF6A-1B6099F64A7EQ35644319-07122421-938A-4FFE-8D52-8BFCC5C9386BQ35668434-02DF89C9-8483-4AB7-9CAF-8495D574FAC3Q35797168-2EA3504F-890E-4903-9D58-27135EC9431AQ36013859-5974C540-6F87-4754-A903-CD86C464D9D1Q36642073-2CD2DD22-4AAF-441F-8A5C-E634763E604EQ37043341-C9A5C216-1FF9-41B8-80EF-5A60C4116C97Q37331764-FE1BA496-C100-4F9F-98B8-87E8674E29DAQ37386451-8AD1F445-3360-43F8-8B84-969BC1615F33Q37436503-D8ABEF66-FDDF-4E5F-8C2B-462BA11AED17Q37458921-4CCC32CA-B9AB-4A8E-A981-7B61563D37E6Q37618990-4FED4D45-1A6E-4E88-8C22-E49E47F98434Q37680975-AD7C87D4-DD4A-4240-B915-347D42D62086Q37715692-1D424E30-DE6C-48C5-9B05-A44F8C2D46A6Q37869464-3A01B131-44D9-4061-B61F-75181F2E0958Q37899952-C75665F6-7D45-4349-B118-9F08F977F199Q37959060-E6A35EB6-3BFC-4D6F-8589-D990A0FECB50Q38013061-50A0203B-E812-44FF-ABC5-7E54DEBF42E5Q38620867-53AD4E86-8376-4085-8CC1-97539CAC5466Q39668546-D8C295C0-0ED3-4DC6-8336-4D262A72E482Q40947117-EDEA901D-EB15-49C3-ABC8-51E1B23BCA8CQ42144631-5C123851-C99E-469F-972E-DD706A067666Q44083134-F4942675-A5FF-4CE8-8143-020A291DE009Q45370584-0DD1B6C6-FF29-4C28-9BF5-B80CA6FF0E2A
P2860
Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory and non-invasive ...... on in coronary artery disease.
@en
Inflammatory and non-invasive ...... on in coronary artery disease.
@nl
type
label
Inflammatory and non-invasive ...... on in coronary artery disease.
@en
Inflammatory and non-invasive ...... on in coronary artery disease.
@nl
prefLabel
Inflammatory and non-invasive ...... on in coronary artery disease.
@en
Inflammatory and non-invasive ...... on in coronary artery disease.
@nl
P2093
P1433
P1476
Inflammatory and non-invasive ...... on in coronary artery disease.
@en
P2093
Dimitrios Th Kremastinos
Georgia D Vamvakou
Ignatios Ikonomidis
John Lekakis
Kimon Stamatelopoulos
P356
10.1016/J.ATHEROSCLEROSIS.2008.02.019
P577
2008-02-29T00:00:00Z